Related Experiment Videos
Studies on the anti-inflammatory properties of thalidomide: effects on polymorphonuclear leukocytes and monocytes
Abstract:
The effects of thalidomide on polymorphonuclear leukocyte (PMN) and monocyte function were studied in vitro. Phagocytosis of latex beads by both PMNs and adherent monocytes was significantly depressed (p less than 0.01) after a 1-hour incubation of cells with 10 microgram/ml of thalidomide. Concentrations of 1 microgram/ml stimulated monocyte phagocytosis (p less than 0.01) but did not influence PMNs. Incubation of monocytes with 10 micrograms/ml resulted in a significant reduction of chemiluminescence (CL) but had no effect at 1 microgram/ml concentrations. There was no significant action on PMN CL at either concentration. Finally, 10 micrograms/ml concentrations of thalidomide were not cytotoxic for either cell type after 18-hour incubations. In conclusion, the results of these studies may at least partially explain the efficacy of thalidomide in some inflammatory conditions.
Insights
Thalidomide at 10 µg/ml impairs polymorphonuclear leukocyte (PMN) and monocyte phagocytosis and reduces monocyte chemiluminescence (CL). These findings suggest thalidomide
Area of Science:
- Immunology
- Pharmacology
Background:
- Thalidomide is known for its anti-inflammatory properties.
- The precise mechanisms underlying thalidomide's effects on immune cells are not fully understood.
Purpose of the Study:
- To investigate the in vitro effects of thalidomide on polymorphonuclear leukocyte (PMN) and monocyte function.
- To explore the impact of thalidomide on phagocytosis and chemiluminescence (CL) in these immune cells.
Main Methods:
- In vitro study using latex bead phagocytosis assay.
- Measurement of chemiluminescence (CL) in PMNs and monocytes.
- Incubation of immune cells with varying concentrations of thalidomide (1 and 10 µg/ml).
- Assessment of cytotoxicity after 18-hour incubation.
Main Results:
- Thalidomide (10 µg/ml) significantly inhibited phagocytosis in both PMNs and monocytes (p < 0.01).
- Lower thalidomide concentration (1 µg/ml) stimulated monocyte phagocytosis but had no effect on PMNs.
- 10 µg/ml thalidomide significantly reduced monocyte chemiluminescence (CL) without affecting PMN CL.
- No significant cytotoxicity was observed at 10 µg/ml after 18 hours.
Conclusions:
- Thalidomide modulates PMN and monocyte functions, including phagocytosis and chemiluminescence.
- The observed effects on immune cell function may contribute to thalidomide's efficacy in managing inflammatory conditions.